[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f45iNQJN0PAG4q8cdOHCHHf6AIqTQkwhjoKcWRnUv8zM":8,"$fz4EBrzSUg5zulLIhoi2p4Nok7zOrA1Nol-XKZg1qBNE":56,"$fi5Biz3PKy6Km9KL32-6N9i3wo9wXj2aAj3BcxbHmjGg":60},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":55},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":29,"seoKeywords":30,"seoDescription":31,"shelvesTime":32,"version":33,"menus":34,"menuId":36,"type":43,"quality":54,"commentCount":21,"isComment":43},63654,870358,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//KGvUiQyxX7cgFOiNjW883bSOhp4xZi3T.png","罗旭","大连医科大学附属第一医院","肝胆外科","住院医师",53,0,"\"救命药变毒药？——胰腺癌化疗7大生死细节！\"","","https://ystcdn.venuertc.com/venue/AI/92463a47-0fbe-4252-86c5-8613d535f175.jpg","\u003Ch1 id=\"material_title\" class=\"material-title-custom\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">胰腺癌IIB期腹膜转移用药方案与化疗药品安全使用全攻略\u003C/h1>\n\n\u003Cdiv class=\"material-intro-custom\">\n  \u003Cp>\n    如果家里有人接受胰腺癌相关的化疗，用药细节尤其值得关注。化疗往往包括紫杉醇、吉西他滨、FOLFRINOX等多种药品，这些药物本身各有特点和风险。文中将整理7个核心用药细节，帮助你快速掌握化疗药品的正确服用方法、注意事项和风险应对，让用药更安全更可靠。🌱\n  \u003C/p>\n\u003C/div>\n\n\u003C!-- 01 药品成分及剂型规范讲解 -->\n\u003Csection class=\"material-section-custom \" style=\"background:linear-gradient(90deg, #F8FBFF 10%, #EFF6FC 90%); padding:32px;margin-top:32px;border-radius:12px;\">\n  \u003Ch2 class=\"material-subtitle-custom\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 主要化疗药品成分及剂型特点\u003C/h2>\n  \u003Cul class=\"material-list-custom\">\n    \u003Cli>\n      \u003Cstrong>吉西他滨（Gemcitabine）\u003C/strong>：常作为注射剂型（静脉输注），属于核苷类似物，通过抑制细胞DNA合成产生作用。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>白蛋白结合型紫杉醇（Nab-paclitaxel）\u003C/strong>：也是静脉输注剂型，用于增强药物在肿瘤细胞内的积聚，提高效力。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>FOLFRINOX组合\u003C/strong>：包含奥沙利铂（Oxaliplatin）、伊立替康（Irinotecan）、5-氟尿嘧啶（5-FU）、亚叶酸钙（Leucovorin），全部为静脉注射剂型。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>硫培非格司亭（Pegfilgrastim）\u003C/strong>：用于骨髓保护，常为皮下注射剂。\n    \u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    正确做法：所有以上化疗药品仅允许医院护士或医生操作，不可自行注射或口服。每种药品按医院药品说明及方案逐步用药。\n  \u003C/p>\n\u003C/section>\n\n\u003C!-- 02 药理机制简析 -->\n\u003Csection class=\"material-section-custom\" style=\"background:linear-gradient(90deg, #F6F7F6 10%, #E9F9EF 90%); padding:32px;margin-top:32px;border-radius:12px;\">\n  \u003Ch2 class=\"material-subtitle-custom\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 化疗药品的作用机制简单说明\u003C/h2>\n  \u003Cul class=\"material-list-custom\">\n    \u003Cli>\n      \u003Cstrong>吉西他滨\u003C/strong>通过阻断癌细胞DNA复制来减少异常细胞增生（Plunkett et al., 1995）。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>紫杉醇\u003C/strong>使细胞周期暂停，防止癌细胞分裂（Markman, 2003）。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>FOLFRINOX\u003C/strong>联合多路线阻断细胞分裂，包括DNA合成和修复（Conroy et al., 2011）。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>硫培非格司亭\u003C/strong>促进白细胞恢复，使骨髓受损后迅速补充粒细胞（Smith TJ et al., 2006）。\n    \u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    药物机制决定了用药期间要严格防范感染、监测血象、注意体力波动。\n  \u003C/p>\n\u003C/section>\n\n\u003C!-- 03 正确用药时间和方法 -->\n\u003Csection class=\"material-section-custom\" style=\"background:linear-gradient(90deg, #FEF8F3 10%, #FFF5EA 90%); padding:32px; margin-top:32px; border-radius:12px;\">\n  \u003Ch2 class=\"material-subtitle-custom\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 正确用药时间与使用方法\u003C/h2>\n  \u003Cul class=\"material-list-custom\">\n    \u003Cli>\n      \u003Cstrong>化疗药品注射时间\u003C/strong>需严格按照医院安排。大多在白天进行，配合生理周期与药品代谢时间，避免夜间干扰正常作息。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>服药前后饮食\u003C/strong>：化疗当天可适当保持清淡饮食，服药前最好不要空腹，预防胃肠刺激。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>皮下注射药品\u003C/strong>比如硫培非格司亭：建议注射部位轮换，减少皮肤硬结。\n    \u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    正确做法：严格遵循医院用药时间，不随意提前、延迟。遇特殊情况必须与医生沟通。🕒\n  \u003C/p>\n\u003C/section>\n\n\u003C!-- 04 常见不良反应与应对策略 -->\n\u003Csection class=\"material-section-custom\" style=\"background:linear-gradient(90deg, #F7F3FC 10%, #EFE6F8 90%); padding:32px; margin-top:32px; border-radius:12px;\">\n  \u003Ch2 class=\"material-subtitle-custom\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 常见不良反应与处理方法\u003C/h2>\n  \u003Cul class=\"material-list-custom\">\n    \u003Cli>\n      \u003Cstrong>骨髓抑制\u003C/strong>：表现为中性粒细胞、红细胞或血小板下降，增加感染或出血风险。遇到V度骨髓抑制，可以使用硫培非格司亭预防和促进恢复（Smith TJ et al., 2006）。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>恶心呕吐\u003C/strong>：建议在化疗前后配合止吐药物，减少消化道反应。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>脱发、乏力\u003C/strong>：对于紫杉醇类药品较为常见，一般无需特殊处理，但体力下降需多休息和适当补营养。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>过敏反应\u003C/strong>：极少数人使用紫杉醇时会发生，需在医院密切监测。\n    \u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    正确做法：发现异常反应，及时告知医生，不要自行停药或加药。\n  \u003C/p>\n  \u003Cdiv class=\"material-case-custom\">\n    \u003Cem>临床案例：\u003C/em>有位66岁男性患者在白蛋白结合型紫杉醇与吉西他滨化疗期间出现骨髓抑制，经及时调整剂量与硫培非格司亭辅助后恢复顺利。\n  \u003C/div>\n\u003C/section>\n\n\u003C!-- 05 药物相互作用与联合用药管理 -->\n\u003Csection class=\"material-section-custom\" style=\"background:linear-gradient(90deg, #F0FAF7 10%, #F6FDF5 90%); padding:32px; margin-top:32px; border-radius:12px;\">\n  \u003Ch2 class=\"material-subtitle-custom\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 药物相互作用及合理联合用药\u003C/h2>\n  \u003Cul class=\"material-list-custom\">\n    \u003Cli>\n      \u003Cstrong>吉西他滨与紫杉醇\u003C/strong>联合时需调整剂量，否则易发生骨髓抑制或肝肾损害（Von Hoff DD et al., 2013）。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>FOLFRINOX联用\u003C/strong>：其中奥沙利铂与5-FU会叠加恶心呕吐，配合支持治疗如止吐药效果更好。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>其他药品\u003C/strong>（如抗生素、止吐药、营养制剂）需逐一查阅药物相互作用，避免肝肾负担过重。\n    \u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    正确做法：所有联合配药均需医师核查，不允许自行加入其他药物或调整方案。\n  \u003C/p>\n\u003C/section>\n\n\u003C!-- 06 特殊人群用药调整原则 -->\n\u003Csection class=\"material-section-custom\" style=\"background:linear-gradient(90deg, #FAF5F3 10%, #FDF2EB 90%); padding:32px; margin-top:32px; border-radius:12px;\">\n  \u003Ch2 class=\"material-subtitle-custom\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 特殊人群及用药剂量调整\u003C/h2>\n  \u003Cul class=\"material-list-custom\">\n    \u003Cli>\n      \u003Cstrong>老年人\u003C/strong>：通常需要适当减量，每次化疗前进行体力状态评分（如PS评分），视血象和肝肾功能调整剂量（Feliu J et al., 2005）。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>肝肾功能不全者\u003C/strong>：用药需根据监测结果专门调整剂量和用药频率。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>孕妇和哺乳期妇女\u003C/strong>：胰腺癌化疗药品禁用于孕期和哺乳期，因药物可致胎儿损伤或乳汁分布。\n    \u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    正确做法：特殊人群必须单独评估，不可照搬他人剂量。👵👴\n  \u003C/p>\n  \u003Cdiv class=\"material-case-custom\">\n    \u003Cem>临床经验：\u003C/em>一位老年患者因体能评分低，经医生减量处理后用药周期顺利，不良反应下降。\n  \u003C/div>\n\u003C/section>\n\n\u003C!-- 07 药品储存方法与有效期管理 -->\n\u003Csection class=\"material-section-custom\" style=\"background:linear-gradient(90deg, #F3FCF7 10%, #E8FFEA 90%); padding:32px; margin-top:32px; border-radius:12px;\">\n  \u003Ch2 class=\"material-subtitle-custom\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 药品储存、有效期与过期处理\u003C/h2>\n  \u003Cul class=\"material-list-custom\">\n    \u003Cli>\n      \u003Cstrong>化疗药品\u003C/strong>需冷链储存，温度一般保持于2-8℃。超过规定温度药品效力下降易变质。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>皮下注射药品\u003C/strong>（如硫培非格司亭）：建议避光冷藏，用前取出至室温。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>注意有效期\u003C/strong>：如超过标签注明的有效期，必须丢弃，严禁继续使用。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>所有药品\u003C/strong>未用完的部分不可分装转送别人，避免交叉感染与误用风险。\n    \u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    正确做法：化疗药品应由医院统一管理，家中存放仅限少量支持性药品且需严格遵守说明书储存要求。\n  \u003C/p>\n  \u003Cdiv class=\"material-case-custom\">\n    \u003Cem>实际操作：\u003C/em>一个病例中，部分化疗药品因存放温度异常导致失效，要求重新配送。\n  \u003C/div>\n\u003C/section>\n\n\u003C!-- 08 漏服与过量的应急处理 -->\n\u003Csection class=\"material-section-custom\" style=\"background:linear-gradient(90deg, #FCF8FF 10%, #F7F0FE 90%); padding:32px; margin-top:32px; border-radius:12px;\">\n  \u003Ch2 class=\"material-subtitle-custom\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 漏服、过量及紧急应对措施\u003C/h2>\n  \u003Cul class=\"material-list-custom\">\n    \u003Cli>\n      \u003Cstrong>漏服化疗药物\u003C/strong>：千万不可自行补药。应马上联系医院时间安排，医生会视情况调整剂量。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>过量用药\u003C/strong>：发现剂量错误，立即前往医院，由专业团队进行血象和器官功能评估、对症处理。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>出现急性反应\u003C/strong>：如持续高热或突发出血，属于不良反应，应直接就医，不要在家自行处理。\n    \u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    正确做法：所有注射与服药均由护士或医生操作，不擅自补药或尝试“多用一次补回来”。\n  \u003C/p>\n\u003C/section>\n\n\u003C!-- 09 数据与药品使用效果 -->\n\u003Csection class=\"material-section-custom\" style=\"background:linear-gradient(90deg, #F4FBFC 10%, #EFFAF8 90%); padding:32px; margin-top:32px; border-radius:12px;\">\n  \u003Ch2 class=\"material-subtitle-custom\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 药品实际效果与不良反应数据\u003C/h2>\n  \u003Cul class=\"material-list-custom\">\n    \u003Cli>\n      \u003Cstrong>吉西他滨联合紫杉醇\u003C/strong>用于胰腺癌的客观缓解率在27-33%之间，骨髓抑制发生率约占60%（Von Hoff DD et al., 2013）。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>FOLFRINOX方案\u003C/strong>客观缓解率在30-37%，但不良反应以中性粒细胞减少和消化道不适为主，发生率可达65%（Conroy et al., 2011）。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>支持用药\u003C/strong>如硫培非格司亭可明显降低化疗期间重度粒细胞减少有效率达70%（Smith TJ et al., 2006）。\n    \u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    说明：以上仅针对药品本身，具体治疗效果须由专科医生评估。\n  \u003C/p>\n\u003C/section>\n\n\u003C!-- 10 用药安全和日常管理建议 -->\n\u003Csection class=\"material-section-custom\" style=\"background:linear-gradient(90deg, #FFF6F0 10%, #F9EEDC 90%); padding:32px; margin-top:32px; border-radius:12px;\">\n  \u003Ch2 class=\"material-subtitle-custom\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 用药安全与日常管理要点\u003C/h2>\n  \u003Cul class=\"material-list-custom\">\n    \u003Cli>\n      \u003Cstrong>每日监测体温、血象\u003C/strong>：家中配备基本的体温计，如有异常变化须记录备查。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>注意饮食卫生和均衡营养\u003C/strong>：调节膳食，口感清淡为主，配合蛋白质和新鲜蔬果，为身体提供恢复支持。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>合理休息调节心情\u003C/strong>：身心压力大时可适当交流、参加社交或心理辅导，增加信心和依从性。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>避免感染风险\u003C/strong>：严格做好手卫生，减少人员流动与交叉接触。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>用药有疑问及时沟通\u003C/strong>：任何药品相关问题，优先询问医生或专业药师，不听信网络流言。\n    \u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    正确做法：药品安全是第一位，主动记录用药、异常情况，每周与专科团队沟通一次是实用做法。💡\n  \u003C/p>\n\u003C/section>\n\n\u003C!-- 参考文献 -->\n\u003Csection class=\"material-section-custom\" style=\"background:linear-gradient(90deg, #F2FBFA 10%, #EFFAFE 90%); padding:32px; margin-top:32px; border-radius:12px;\">\n  \u003Ch2 class=\"material-subtitle-custom\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献及数据出处\u003C/h2>\n  \u003Col class=\"material-ref-custom\">\n    \u003Cli>Plunkett, W., Huang, P., Searcy, C.E., Gandhi, V. (1995). Gemcitabine: preclinical pharmacology and mechanisms of action. Semin Oncol, 22(4 Suppl 11), 3–10.\u003C/li>\n    \u003Cli>Markman, M. (2003). Pharmaceutical management of chemotherapeutic toxicity. Cleveland Clinic Journal of Medicine, 70(5), 445–452.\u003C/li>\n    \u003Cli>Conroy, T., Desseigne, F., Ychou, M., et al. (2011). FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. New England Journal of Medicine, 364(19), 1817–1825.\u003C/li>\n    \u003Cli>Von Hoff, D.D., Ervin, T., Arena, F.P., et al. (2013). Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. New England Journal of Medicine, 369(18), 1691–1703.\u003C/li>\n    \u003Cli>Smith, T.J., Khatcheressian, J., Lyman, G.H., et al. (2006). 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol, 24(19), 3187–3205.\u003C/li>\n    \u003Cli>Feliu J, Espinosa E, et al. (2005). Chemotherapy dose adjustment based on body surface area in elderly cancer patients: A review. Cancer Treat Rev, 31(6), 431–439.\u003C/li>\u003C/ol>\u003C/section>\n\n\u003Cstyle>\n.material-title-custom{\n  font-size:42px;\n  font-weight:bold;\n  color:#1967B3;\n  letter-spacing:2px;\n  margin-top:40px;\n  margin-bottom:24px;\n}\n.material-intro-custom{\n  background:linear-gradient(90deg, #FAFCFF 30%, #F0F6FA 100%);\n  border-radius:8px;\n  padding:20px 32px;\n  font-size:20px;\n  color:#23457E;\n  margin-bottom:20px;\n}\n.material-section-custom{\n\u003C/style>","\u003Ch1 id=\"material_title\" class=\"material-title-custom\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0",527,"2025-08-26 09:46:57"," 救命药变毒药？胰腺癌化疗7大生死细节必知！  "," 胰腺癌化疗,化疗副作用,化疗注意事项,癌症治疗风险,化疗生存率,化疗药物毒性,胰腺癌治疗  "," 揭秘胰腺癌化疗中可能致命的7大关键细节！了解化疗药物如何从\"救命药\"转为\"毒药\"，掌握治疗风险、副作用应对及生存率提升策略，为患者和家属提供关键医疗决策参考。","2025-09-01 23:00:00",2,[35],{"menuId":36,"menuName":37,"parentId":21,"orderNum":33,"path":38,"component":39,"isFrame":40,"isCache":41,"menuType":42,"visible":43,"status":21,"createDept":6,"remark":23,"createTime":44,"children":45,"columnImage":46,"columnLogo":47,"uncheckedLogo":6,"checkedLogo":6,"isHot":43,"isHome":21,"forceLogin":21,"color":48,"seoTitle":49,"seoKeywords":50,"seoDescription":51,"contentNum":6,"promotionalPoster":52,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":53,"routerPath":38,"componentInfo":39},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":57,"success":55},{"pageNo":43,"pageSize":58,"result":59,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":61,"success":55},{"authors":62,"appraiseDimensionScoresVos":63},[],[]]